In the attempt to identify classic driver mutations in B cell malignancy such as IDH in AML or glioma, recent sequencing approaches have not revealed similarly prominent metabolism genes as direct driver mutations of lymphomas [26,27]. The gene discussed is IDH2; the disease is central nervous system cancer.